| Lightcalls.com |
|
|
![]() |
In classical Sanskrit paragraphs t...In classical Sanskrit paragraphs there is mention of a "small, thorny, magnify bush with long branches and little fulvous flowers known as Bala," in Bengalese, according to Birgit Heyn's Ayurveda: The Indian Art of Natural Medicine & Life Extension. Sida cordifolia--heart-shaped plant that actually helps the heart...and more This thorny weed, related to the marsh mallow plant, called Sida cordifolia in Latin (with cordifolia referring to its heart-shaped leaves), is common of the most valuable botanicals in Ayurvedic Medicine, having been used according to Hindu physicians since ancient times. Other names for this astringent, tonic herb include: Khareti (Hind)); nation mallow; Marubakingojikuwa (Japanese); Kedong (Chinese); Ba-la (Tibetan); Kelulut pulih (Malaysian); and Arival (Tamil). Used historically for its aphrodisiac events it is today brought to bear for spasmotic cough and urinary infections. For flushs the root has been mixed with ginger. Traditionally, the plant has been used as an astringent, an antidote for scorpion stings and snake bites, and for: tuberculosis; chronic dysentery; rheumatism; gonorrhea; nervous, urinary, and cardiac diseases, A.A. Leslie Gunatilaka, and colleagues hint in their paper that appeared in the Journal of Medicinal Plant Research (1980) Non-human studies have pointed to this valuable weed's antibacterial, antifungal, and antiviral properties. Test-tube studies, in fact, have shown anti-cancer activity against nasopharyngeal (nose and pharynx) carcinoma. The plant figures prominently in rasayana medicines, being a rejuvenating tonic herb appropriate for a wide variety of Vata disorders. Its traditional use in Ayurvedic Medicine as a cardiac stimulant and bronchodilator (helping to spread constricted airway passages leading to the lungs) has frequently been associated with helping those suffering from asthma. Rasayanas, or rejuvenators, also "build immunity, well-being, and vitality for the entire system" intimate Peter Anselmo and James s Brooks, M.D., in their 1996 volume Ayurvedic Secrets to Longevity Total Health. Although there are about seven to eight species of "Bala," Sanskrit writers alone mention five species under the name "pancha bale": Sida acuta, s cordifolia, Sida racemosa, Sida rhombifolia, and Sida rhomboidea. cordifolia's cardiac-function-rejuvenating validitys have been attributed to the appearance of natural ephedrine (or an ephedrine-like compound) in the aerial parts of the plant. Nevertheless, it also contains: fatty oil, phytosterol, potassium nitrate, resin, resin acids, and alkaloids (nitrogenous organic compounds) -- the main alkaloid being asparagin. Tinospora cordifolia -- another choice rejuvenator This shrub is a real climber, individual that is especially fond of latching onto neem tree possibly because of one similar qualities they share. Also called Guduchi, this botanical is bitter (containing berberine and other alkalaids) and hasty Although its traditional use points to all three doshas, it is used primarily for Pitta problems Its gunpowder controls fever and serves as an aphrodisiac; the juice of the unfaded plant has been given, with honey for diabetes; and a water-based extract from it is used for chronic diarrhea, bloody flux headaches, blood-sugar-metabolism imbalances, and -- perhaps greatest in quantity importantly -- as a diuretic, for liver-related disturbances, for infection, and for inflammation. It has also shown certain blood-pressure-lowering capabilities. As an an anti-diabetes addition In a landmark study by way of S.S. Gupta, and colleagues, from 1967 (Indian Journal of Medical Research 55: 733-745) it was refer toed that this botanical exhibits beneficial imports on fasting-blood-sugar levels, glucose tolerance, and adrenaline-induced hyperglycemia. As a diuretic. In line with studying T cordifolia's events on urinary excretion (output), Sunanda s Nayampalli, et al., published a cogitation in the Journal of Postgraduate Medicine, in 1988 In their clinical trial, 10 healthy male tenders aged 30 to 42 years, were admitted into the clinical pharmacology ward of Bombay, India's KEM Hospital. When an extract of this plant was administered in a single dose ranging from 50 mg up to 1250 ma, urine bulk increased, while blood electrolyte flushs remained stable. As a liver-protectant/Jaundice treatment. Liver-protection is an area in which T cordifolia has shown a certain quantity of outstanding results-specifically in cases of obstructive jaundice, a yellowing condition which take places when the flow of liver-produced digestive bile is obstructed from reaching the duodenum, part of the small intestines. We can point to sum of two units studies on T. cordifolia and obstructive jaundice that have been carried not at home by N.N. Rege, and colleagues, undivided from 1989 and the other from 1993 In the first close attention (from 1989), all 16 patients with obstructive jaundice also had significantly lowered immune function, particularly that shown according to lowered levels of polymorphonuclear (PMN) cells "As surgery is not always possible," the authors note, "especially in high-risk patients, an alternate approach slirected at" boosting the immune body seems to be the ticket. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |